Pennsylvania HB2592 amends the Patient Test Result Information Act to require notification of prostate-specific antigen test results and establish.
Pennsylvania HB2592 amends the Patient Test Result Information Act to require entities performing prostate-specific antigen tests to notify patients or their designees when abnormal levels are detected. The notice must include details such as the ordering health care practitioner's name, the test date, and a summary of the results. The Department of Health must conduct compliance reviews, investigate complaints, and establish a publicly accessible complaint procedure.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.